SKI Market

Indian Indices

Sensex

85,524.84 -42.64
( -0.05%)

Global Indices

Nasdaq

48,384.75 228.85
(0.48%)

Dow Jones

6,899.94 44.44
(0.65%)

Hang Seng

50,367.86 -34.53
(-0.07%)

Nikkei 225

9,896.28 30.31
(0.31%)

Forex

USD-INR

89.57 -0.68
(-0.75%)

EUR-INR

104.88 -0.99
(-0.94%)

GBP-INR

119.79 -0.93
(-0.77%)

JPY-INR

0.57 -0.01
(-2.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Veedol Corporation Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

590005

INE484C01030

432.37764

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VEEDOL

22.92

2930.19

EPS(TTM)

Face Value()

Div & Yield %

73.37

3.13

Back

Biogen Pharmachem Industries reports standalone net loss of Rs 0.49 crore in the September 2025 quarter

Nov 07,2025

Net Loss of Biogen Pharmachem Industries reported to Rs 0.49 crore in the quarter ended September 2025 as against net loss of Rs 1.00 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

85,524.84 -42.64 ( -0.05%)

48,384.75 228.85 (0.48%)

6,899.94 44.44 (0.65%)

50,367.86 -34.53 (-0.07%)

9,896.28 30.31 (0.31%)

89.57 -0.68 (-0.75%)

104.88 -0.99 (-0.94%)

119.79 -0.93 (-0.77%)

0.57 -0.01 (-2.03%)